(Total Views: 709)
Posted On: 08/06/2020 6:32:51 PM
Post# of 153916
Oh, I agree that we need to do exactly what the FDA has asked us to do. No argument there.
My issue is with the lack of urgency on the part of the FDA. They should ask the DSMC for the numbers they saw, and then call us and tell us to start an interim analysis.
They need to step up.
My issue is with the lack of urgency on the part of the FDA. They should ask the DSMC for the numbers they saw, and then call us and tell us to start an interim analysis.
They need to step up.
(0)
(0)
